$279.83
+
$2.14 (0.76%)
End-of-day quote: 05/03/2024
NYSE:BIO
Bio-Rad Laboratories Inc Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $573.55 | $591.94 | 0.00% | 1 | $218.93B |
| DHR | Danaher | NYSE | Outperform | $247.40 | $260.33 | 0.00% | 4 | $183.25B |
| A | Agilent Technologies | NYSE | Outperform | $140.61 | $138.82 | 0.00% | 10 | $41.21B |
| MTD | Mettler-Toledo International | NYSE | Hold | $1.25k | $1.12k | 0.00% | 0 | $26.75B |
| WAT | Waters | NYSE | Hold | $319.86 | $323.50 | 0.00% | 2 | $18.97B |
| ILMN | Illumina | NasdaqGS | Outperform | $118.98 | $159.28 | 0.00% | 9 | $18.95B |
| AVTR | Avantor | NYSE | Outperform | $24.87 | $23.25 | 0.00% | 19 | $16.89B |
| PKI | PerkinElmer | NYSE | Outperform | $102.82 | $121.84 | 0.00% | 1 | $12.49B |
| BRKR | Bruker | NasdaqGS | Outperform | $72.52 | $73.64 | 0.00% | 1 | $10.18B |
| COHR | Coherent | NasdaqGM | - | $33.97 | $258.00 | 0.00% | 0 | $6.61B |
| LAB | Standard BioTools | NasdaqGS | Buy | $2.48 | $4.00 | 0.00% | 1 | $948.50M |
| PACB | Pacific Biosciences of Califor... | NasdaqGS | Outperform | $1.99 | $12.67 | 0.00% | 4 | $449.37M |
| HBIO | Harvard Bioscience | NasdaqGM | Buy | $3.92 | $7.00 | 0.00% | 2 | $165.87M |
| EQTL | Equitech International | OTCPK | - | $1.40 | $0.00 | 0.00% | 0 | $2.56M |
| ASPT | Haber | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.02M |
| MDIT | Medite Cancer Diagnostics | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.01M |
| OMRX | Orthometrix | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
| LFPI | LifePoint | OTCPK | - | $0.00 | $5.50 | 0.00% | 0 | $0.00M |
